Protein zero gene expression is regulated by the glial transcription factor Sox10

Molecular and Cellular Biology

Volumn 20, Issue 9, 2000, Pages 3198-3209

  Peirano, Reto I ^a   Goerich, Derk E ^a   Riethmacher, Dieter ^a   Wegner, Michael ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSFECTION; GLIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; RAT;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DNA-BINDING PROTEINS; EMBRYO; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; HUMANS; IN SITU HYBRIDIZATION; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; MYELIN P0 PROTEIN; PROMOTER REGIONS (GENETICS); RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL NERVES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0034004661     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.9.3198-3209.2000     Document Type: Article

References (52)

1. Baron, P., M. Shy, H. Honda, M. Sessa, J. Kamholz, and D. Pleasure. 1994. Developmental expression of P0 mRNA and P0 protein in the sciatic nerve and the spinal nerve roots of the rat. J. Neurocytol. 23:249-257.
2. Bell, D. M., K. K. H. Leung, S. C. Wheatley, L. J. Ng, S. Zhou, K. W. Ling, M. H. Sham, P. Koopman, P. P. L. Tam, and K. S. E. Cheah. 1997. Sox9 directly regulates the type-II collagen gene. Nat. Genet. 16:174-178.
3. Blanchard, A. D., A. Sinanan, E. Parmantier, R. Zwart, L. Broos, D. Meijer, C. Meier, K. R. Jessen, and R. Mirsky. 1996. Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J. Neurosci. Res. 46:630-640.
4. Bondurand, N., A. Kobetz, V. Pingault, N. Lemort, F. Encha-Razavi, G. Couly, D. E. Goerich, M. Wegner, M. Abitbol, and M. Goossens. 1998. Expression of the SOX10 gene during human development. FEBS Lett. 432:168-172.
5. Bondurand, N., K. Kuhlbrodt, V. Pingault, J. Enderich, M. Sajus, N. Tommerup, M. Warburg, R. C. Hennekam, A. P. Read, M. Wegner, and M. Goossens. 1999. A molecular analysis of the Yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies. Hum. Mol. Genet. 8:1785-1789.
6. Brown, A. M., and G. Lemke. 1997. Multiple regulatory elements control transcription of the peripheral myelin protein zero gene. J. Biol. Chem. 272:28939-28947.
7. Giese, K. P., R. Martini, G. Lemke, P. Soriano, and M. Schachner. 1992. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-576.
8. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
9. Gossen, M., S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769.
10. Hagedorn, L., U. Suter, and L. Sommer. 1999. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-(beta) family factors. Development 126:3781-3794.
11. Harley, V. R., R. Lovell-Badge, and P. N. Goodfellow. 1994. Definition of a consensus DNA binding site for SRY. Nucleic Acids Res. 22:1500-1501.
12. He, X., R. Gerrero, D. M. Simmons, R. E. Park, L. C. R., L. W. Swanson, and M. G. Rosenfeld. 1991. Tst-1, a member of the POU domain gene family, binds the promoter of the gene encoding the cell surface adhesion molecule Po. Mol. Cell. Biol. 11:1739-1744.
13. Herbarth, B., V. Pingault, N. Bondurand, K. Kuhlbrodt, I. Hermans-Borgmeyer, A. Puliti, N. Lemort, M. Goossens, and M. Wegner. 1998. Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc. Natl. Acad. Sci. USA 95:5161-5165.
14. Inoue, K., Y. Tanabe, and J. R. Lupski. 1999. Myelin deficiencies in both the central and peripheral nervous system associated with a SOX10 mutation. Ann. Neurol. 46:313-318.
15. Inoue, T., O. Chisaka, H. Matsunami, and M. Takeichi. 1997. Cadherin-6 expression transiently delineates specific rhombomeres, other neural tube subdivisions, and neural crest subpopulations in mouse embryos. Dev. Biol. 183:183-194.
16. Kamholz, J., M. Sessa, S. Scherer, H. Vogelbacker, K. Mokuno, P. Baron, L. Wrabetz, M. Shy, and D. Pleasure. 1992. Structure and expression of proteolipid protein in the peripheral nervous system. J. Neurosci. Res. 31:231-244.
17. Keller, M. P., and P. F. Chance. 1999. Inherited neuropathies: from gene to disease. Brain Pathol. 9:327-341.
18. Kuhlbrodt, K., B. Herbarth, E. Sock, J. Enderich, I. Hermans-Borgmeyer, and M. Wegner. 1998. Cooperative function of POU proteins and Sox proteins in glial cells. J. Biol. Chem. 273:16050-16057.
19. Kuhlbrodt, K., B. Herbarth, E. Sock, I. Hermans-Borgmeyer, and M. Wegner. 1998. Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18:237-250.
20. Kuhlbrodt, K., C. Schmidt, E. Sock, V. Pingault, N. Bondurand, M. Goossens, and M. Wegner. 1998. Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients. J. Biol. Chem. 273:23033-23038.
21. Lee, M.-J., A. Brennan, A. Blanchard, G. Zoidl, Z. Dong, A. Tabernero, C. Zoidl, M. A. R. Dent, K. R. Jessen, and R. Mirsky. 1997. P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol. Cell. Neurosci. 8:336-350.
22. Lefebvre, V., W. Huang, V. R. Harley, P. N. Goodfellow, and B. DeCrombrugghe. 1997. Sox9 is a potent activator of the chondrocyte-specific enhancer of the proα1(II) collagen gene. Mol. Cell. Biol. 17:2336-2346.
23. Lefebvre, V., P. Li, and B. de Crombrugghe. 1998. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17:5718-5733.
24. Lemke, G. 1993. The molecular genetics of myelination: an update. Glia 7:263-271.
25. Lemke, G. 1988. Unwrapping the genes of myelin. Neuron 1:535-543.
26. Lemke, G., and R. Axel. 1985. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40:501-508.
27. Lemke, G., E. Lamar, and J. Patterson. 1988. Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron 1:73-83.
28. Mertin, S., S. G. McDowall, and V. R. Harley. 1999. The DNA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res. 27:1359-1364.
29. Messing, A., R. R. Behringer, J. P. Hammang, R. D. Palmiter, R. L. Brinster, and G. Lemke. 1992. P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice. Neuron 8:507-520.
30. Messing, A., R. R. Behringer, L. Wrabetz, J. P. Hammang, G. Lemke, R. D. Palmiter, and R. L. Brinster. 1994. Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen. J. Neurosci. 14:3533-3539.
31. Mirsky, R., and K. R. Jessen. 1999. The neurobiology of Schwann cells. Brain Pathol. 9:293-311.
32. Monuki, E. S., R. Kuhn, G. Weinmaster, B. Trapp, and G. Lemke. 1990. Expression and activity of the POU transcription factor SCIP. Science 249: 1300-1303.
33. Murphy, P., P. Topilko, S. Schneider-Maunoury, T. Seitanidou, A. Baronvan Evercooren, and P. Charnay. 1996. The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 122:2847-2857.
34. Ng, L.-J., S. Wheatley, G. E. O. Muscat, J. Conway-Campbell, J. Bowles, E. Wright, D. M. Bell, P. P. L. Tam, K. S. E. Cheah, and P. Koopman. 1997. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183:108-121.
35. Pevny, L. H., and R. Lovell-Badge. 1997. Sox genes find their feet. Curr. Opin. Genet. Dev. 7:338-344.
36. Pingault, V., N. Bondurand, K. Kuhlbrodt, D. E. Goerich, M.-O. Prehu, A. Puliti, B. Herbarth, I. Hermans-Borgmeyer, E. Legius, G. Matthijs, J. Amiel, S. Lyonnet, I. Ceccherini, G. Romeo, J. C. Smith, A. P. Read, M. Wegner, and M. Goossens. 1998. Sox10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet. 18:171-173.
37. Prior, H. M., and M. A. Walter. 1996. Sox genes: architects of development. Mol. Med. 2:405-412.
38. Pusch, C., E. Hustert, D. Pfeifer, P. Südbeck, R. Kist, B. Roe, Z. Wang, R. Balling, N. Blin, and G. Scherer. 1998. The SOX10/Sox10 gene from human and mouse: sequence, expression, and transactivation by the encoded HMG domain transcription factor. Hum. Genet. 103:115-123.
39. Renner, K., H. Leger, and M. Wegner. 1994. The POU-domain protein Tst-1 and papovaviral T-antigen function synergistically to stimulate glia-specific gene expression of JC virus. Proc. Natl. Acad. Sci. USA 91:6433-6437.
40. Scherer, S. 1997. The biology and pathobiology of Schwann cells. Curr. Opin. Neurol. 10:386-397.
41. Schreiber, J., E. Sock, and M. Wegner. 1997. The regulator of early gliogenesis glial cells missing is a transcription factor with a novel type of DNA-binding domain. Proc. Natl. Acad. Sci. USA 94:4739-4744.
42. Shapiro, L., J. P. Doyle, P. Hensley, D. R. Colman, and W. A. Hendrickson. 1996. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17:435-449.
43. Sock, E., J. Enderich, M. G. Rosenfeld, and M. Wegner. 1996. Identification of the nuclear localization signal of the POU domain protein Tst-1/Oct6. J. Biol. Chem. 271:17512-17518.
44. Solomon, M. J., F. Strauss, and A. Varshavsky. 1986. A mammalian high mobility group protein recognizes any stretch of six A.T base pairs in duplex DNA. Proc. Natl. Acad. Sci. USA 83:1276-1280.
45. Southard-Smith, E. M., M. Angrist, J. S. Ellison, R. Agarwala, A. D. Baxevanis, A. Chakravarti, and W. J. Pavan. 1999. The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res. 9:215-225.
46. Southard-Smith, E. M., L. Kos, and W. J. Pavan. 1998. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 18:60-64.
47. Wegner, M. 1999. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27:1409-1420.
48. Wegner, M., D. W. Drolet, and M. G. Rosenfeld. 1993. Regulation of JC virus by the POU-domain transcription factor Tst-1, implications for progressive multifocal leukoencephalopathy. Proc. Natl. Acad. Sci. USA 90:4743-4747.
49. Zhou, G., V. Lefebvre, Z. Zhang, H. Eberspaecher, and B. de Crombrugghe. 1998. Three high-mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J. Biol. Chem. 273:14989-14997.
50. Zorick, T. S., and G. Lemke. 1996. Schwann cell differentiation. Curr. Opin. Cell Biol. 8:870-876.
51. Zorick, T. S., D. E. Syroid, E. Arroyo, S. S. Scherer, and G. Lemke. 1996. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol. Cell. Neurosci. 8:129-145.
52. Zorick, T. S., D. E. Syroid, A. Brown, T. Gridley, and G. Lemke. 1999. Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development 126:1397-1406.